EUDA Health (NASDAQ:EUDA) Shares Set to Reverse Split on Monday, March 23rd

EUDA Health Holdings Limited (NASDAQ:EUDA) shares are set to reverse split on Monday, March 23rd. The 1-20 reverse split was recently announced. The number of shares owned by shareholders will be adjusted after the market closes on Sunday, March 22nd.

EUDA Health Trading Down 15.2%

EUDA stock traded down $0.07 on Thursday, hitting $0.40. The company’s stock had a trading volume of 472,240 shares, compared to its average volume of 149,615. The stock has a market cap of $15.07 million, a price-to-earnings ratio of -3.32 and a beta of -0.11. The firm has a 50 day moving average of $1.11 and a two-hundred day moving average of $1.93. EUDA Health has a 1 year low of $0.36 and a 1 year high of $4.30.

Wall Street Analysts Forecast Growth

A number of equities analysts recently issued reports on the company. Weiss Ratings reissued a “sell (d)” rating on shares of EUDA Health in a report on Friday, January 9th. Greenridge Global lowered their target price on EUDA Health from $6.00 to $2.75 and set a “buy” rating on the stock in a research note on Monday, March 9th. One equities research analyst has rated the stock with a Buy rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, EUDA Health currently has an average rating of “Hold” and an average target price of $2.75.

Hedge Funds Weigh In On EUDA Health

A hedge fund recently raised its stake in EUDA Health stock. Citadel Advisors LLC lifted its holdings in shares of EUDA Health Holdings Limited (NASDAQ:EUDA) by 57.7% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 44,631 shares of the company’s stock after purchasing an additional 16,321 shares during the period. Citadel Advisors LLC owned about 0.12% of EUDA Health worth $78,000 as of its most recent SEC filing. 4.35% of the stock is currently owned by institutional investors.

EUDA Health Company Profile

EUDA Health, Inc (NASDAQ:EUDA) is a healthcare technology company focused on the development and commercialization of digital health solutions and energy-based medical devices for women’s intimate health. The company’s platform combines non-invasive treatment devices with software-driven patient monitoring and analytics to support pelvic floor function, address stress urinary incontinence and enhance vaginal tissue health.

EUDA Health’s core product offerings utilize low-intensity radiofrequency energy delivered through proprietary handpieces to promote tissue remodeling and muscle activation.